Clinical Trial Update: Dose-range Finding Treosulfan-based Conditioning [Phase 1, Phase 2]

View source ↗

Summary

A dose-range finding study of treosulfan-based conditioning for hematological malignancies completed Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: medac GmbH | Conditions: Hematological Malignancies | Phase 1, Phase 2 | Status: COMPLETED